MilanaVeraDolezalMDMSci(She/Her)
Oncology • Emeryville, CABreast Cancer, Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology
Associate Professor/Clinical educator Stanford School of Medicine https://med.stanford.edu/profiles/milana-dolezal
Dr. Dolezal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5800 Hollis Street
4th floor Medical Oncology Hematology
Emeryville, CA 94608Phone+1 510-901-3552Fax+1 510-806-2557- Is this information wrong?
Summary
- Breast cancer specialist, Cancer survivorship/supportive care director, Clinical trials advocate, passionate about living strong and committed to teaching people about healthy living both during and after treatments. Veteran triathlete and iron(wo)man along with Tour of Hope across USA bicycle rider. Speaker/consultant for several companies involved in molecular platforms and targeted personalized cancer treatment options.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 1999 - 2002
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2024- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Publications & Presentations
PubMed
- 6 citationsConcomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (T...Joseph M. Letourneau, Flor Juarez-Hernandez, Kaitlyn Wald, Salustiano Ribeiro, Ange Wang, Charles E. McCulloch, Evelyn Mok-Lin, Milana Dolezal, A. Jo Chien, Marcelle I...> ;Journal of Assisted Reproduction and Genetics. 2021 Jul 26
- 34 citationsFertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation ...Joseph M. Letourneau, Kaitlyn Wald, Nikita Sinha, Flor Juarez-Hernandez, E. Harris, Marcelle I. Cedars, Charles E. McCulloch, Milana Dolezal, A. Jo Chien, Mitchell P. ...> ;Cancer. 2020 Feb 1
- 7 citationsModeling notch signaling in normal and neoplastic hematopoiesis: global gene expression profiling in response to activated notch expression.Uma Ganapati, Hongying Tina Tan, Maureen Lynch, Milana Dolezal, Sven de Vos, Judith C. Gasson> ;Stem Cells. 2007 Aug 1
- Join now to see all
Press Mentions
Considering Novel Therapy for HER2+ Metastatic Breast CancerMay 20th, 2022
Hospital Affiliations
Stanford Health CarePalo Alto, California
External Links
- Stanford https://stanfordhealthcare.org/doctors/d/milana-dolezal.html
- http://cancersurvivorshipsexualhealth.eventbrite.com/http://cancersurvivorshipsexualhealth.eventbrite.com/
- http://cancersurvivorshipsexualhealth.eventbrite.com/http://cancersurvivorshipsexualhealth.eventbrite.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
